NCT06193018

Brief Summary

Work-related musculoskeletal disorders (WRMSD), multifactorial diseases that affect the working population and which can be caused and/or aggravated by work and occupational exposures, continue to Prevention interventions for these pathologies have recently made use of technological advancement, which has made external devices available for the assistance of human activities, i.e. occupational exoskeletons (EXO). Despite the suggestive potential inherent in these devices, their actual adoption in the working and industrial world is still uncertain due to the absence of evidence on their effectiveness, safety of use and appropriateness. The use of EXO increases the user's ability to carry out manual tasks in different work contexts, lightening the perception of physical effort and promoting higher levels of safety, as well as promoting better performance. These advantages derive from the effective reduction in muscle activity that the use of EXO allows. A certain variability in the effects was referred to factors such as the type of work task, the type of exoskeleton adopted, the duration of use of the exoskeleton, as well as to individual differences and different behaviours at work. The field studies, carried out so far in the automotive, manufacturing, logistics and agriculture sectors, are fundamental to understanding the actual effectiveness, practicality, safety and acceptance of EXO by the user. This project contributes to the expansion of knowledge relating to the prevention of WRMSD through EXO, applying wearable sensors in a real working situation such as the textile sector, in which the female gender constitutes the majority of the workforce.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2023

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

February 19, 2025

Status Verified

January 1, 2025

Enrollment Period

1.5 years

First QC Date

December 21, 2023

Last Update Submit

February 17, 2025

Conditions

Keywords

Wearable devicesElectromyographyErgonomicsDigital signal processingOverhead workUpper limbs supporting exoskeleton

Outcome Measures

Primary Outcomes (1)

  • muscular activity of the shoulder sectors

    Electromyography root-mean-square (RMS) of the shoulder sectors (anterior and medial deltoid) and lumbar spine was determined in the EXO and in the FREE condition

    baseline

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

workers at the company, on a voluntary basis

You may qualify if:

  • workers of the textile sector

You may not qualify if:

  • acute disabling pathologies or presence of internal complications contraindicating the carrying out of activities involving the lumbar- pelvic sector

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

ICS Maugeri

Telese Terme, Bari, 82037, Italy

Location

ICS Maugeri

Montescano, Pavia, 27040, Italy

Location

ICS Maugeri

Bari, 70100, Italy

Location

ICS Maugeri

Pavia, 27100, Italy

Location

Study Officials

  • Edda Capodaglio, PhD

    Istituti Clinici Scientifici Maugeri SpA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2023

First Posted

January 5, 2024

Study Start

May 10, 2023

Primary Completion

November 11, 2024

Study Completion

December 20, 2024

Last Updated

February 19, 2025

Record last verified: 2025-01

Locations